If you are a fan of an early dinner, you may be inadvertently decreasing your risk of prostate and breast cancer , according to a new study.
Researchers from the Barcelona Institute for Global Health have analysed the link between cancer risk and the timing of meals and sleep.
While previous studies have looked at the link between certain foods and cancer risk, few studies have looked at the timing of eating.
Evgen Pharma (LON:EMH) is a clinical stage drug development company whose lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. The company is carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. Evgen Pharma’s objective is to become the leading company in the development of pharmaceuticals that activate the antioxidant response element, Nrf2.